Organon (OGN) Return on Equity (2020 - 2026)

Organon (OGN) has reported Return on Equity for 7 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Equity fell 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (down 1.0% YoY), while the FY2025 annual figure was 0.0%, down 4.0% from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at Organon, up from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.1% in Q2 2024, with the low at 0.95% in Q1 2024.
• Average Return on Equity over 5 years is 0.06%, with a median of 0.0% recorded in 2026.
• Across the five-year window, Return on Equity tumbled 95 bps in 2024 and surged 97 bps in 2025, its largest moves.
• Year by year, Return on Equity stood at 0.0% in 2022, then tumbled by 107135 bps to 0.03% in 2023, then soared by 158 bps to 0.02% in 2024, then slumped by 87 bps to 0.0% in 2025, then soared by 32 bps to 0.0% in 2026.
• According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.